LumiraDx Limited Warrant
LMDXW
LMDXW was delisted on the 8th of January, 2024.
4 hedge funds and large institutions have $42.9K invested in LumiraDx Limited Warrant in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 11 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
73% less funds holding
Funds holding: 15 → 4 (-11)
88% less capital invested
Capital invested by funds: $344K → $42.9K (-$301K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 11
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LP
LMR Partners
London,
United Kingdom
|
-$1.73K |
| 2 |
Balyasny Asset Management
Chicago,
Illinois
|
-$1.38K |
| 3 |
KL
KIM LLC
Wichita,
Kansas
|
-$938 |
| 4 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
-$314 |
| 5 |
Walleye Capital
New York
|
-$258 |
LMDXW Hedge Fund Activity: Q1 2024 in Review
4 of the 6,959 institutional investors tracked by Wall St. Rank reported a position in LumiraDx Limited Warrant (LMDXW) for Q1 2024, worth a combined $42.9K — down 88% from $344K a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of LMDXW and 0 opened new positions — a net loss of 11 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was LMR Partners, exiting entirely with an estimated $1.73K sold.
- 4 institutional investors held LumiraDx Limited Warrant (LMDXW) as of Q1 2024, down from 15 in Q4 2023.
- Funds reported $42.9K of LumiraDx Limited Warrant stock for Q1 2024, down 88% quarter-over-quarter.
- 0 funds opened new LumiraDx Limited Warrant positions in Q1 2024 and 11 closed out, a net change of -11 holders.
- The largest LumiraDx Limited Warrant seller in Q1 2024 was LMR Partners, an estimated $1.73K sold.
Based on aggregated 13F filings for Q1 2024.